---
title: "Rekvina Labs Ltd (526075) — Share Price, Financials & Analysis"
symbol: "526075"
company: "Rekvina Labs Ltd"
canonical: "https://tapetide.com/stocks/526075"
isin: "INE092O01028"
nse_symbol: "REKVINALABORATORIESLTD"
bse_code: "526075"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 64.7
generated_at: "2026-09-13T18:50:19.306Z"
---

# Rekvina Labs Ltd (526075)

Canonical page: https://tapetide.com/stocks/526075

## Company

- **NSE Symbol:** REKVINALABORATORIESLTD
- **BSE Code:** 526075
- **ISIN:** INE092O01028
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** rekvinalaboratories.com

## About

[1]Rekvina Laboratories Limited is engaged in the manufacturing and marketing of pharmaceutical formulations.[2]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:43:59.832343Z.

- **Market Cap:** ₹64.7 Cr
- **Classification:** Microcap
- **P/E (reported):** -187.9
- **EPS (TTM):** ₹-0.27
- **Book Value:** ₹3.47
- **Price to Book:** 16.77
- **Dividend Yield:** 0%
- **ROE:** 20.74%
- **ROCE:** 20.74%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹1.3 Cr
- **Net Income:** ₹-0.3 Cr
- **EBITDA:** ₹-0.3 Cr
- **52-Week High:** ₹58.24
- **52-Week Low:** ₹6.75
- **RSI (14):** 92.77

## Key Insights

### Strengths

- Promoter holding has increased by 35.7% over last quarter.

### Weaknesses

- Company has low interest coverage ratio.
- Company has high debtors of 172 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -210.53% | — | — |
| ebitda margin growth | 0% | — | — | — |
| net income growth | 0% | 200% | — | 200% |
| revenue growth | 0% | — | — | — |
| roce | — | -49.75% | 146.9% | -94.88% |
| roe | — | -49.75% | 23.47% | -103.66% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0.35 | 0.72 | 0.67 |
| Expenses | 0.01 | 0 | 0 | 0 | 0.07 | 0.02 | 0.04 | 0.04 | 0.23 | 0.47 | 0.78 | 0.79 |
| Operating Profit | -0.01 | 0 | 0 | 0 | -0.07 | -0.02 | -0.04 | -0.04 | -0.03 | -0.12 | -0.06 | -0.12 |
| OPM % | — | — | — | — | — | — | — | — | -15 | -34.29 | -8.33 | -17.91 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.01 | 0 | 0 | 0 | -0.07 | -0.02 | -0.04 | -0.04 | -0.03 | -0.12 | -0.06 | -0.12 |
| Tax % | 0 | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0.01 | 0 | 0 | 0 | -0.07 | -0.02 | -0.04 | -0.04 | -0.03 | -0.12 | -0.06 | -0.12 |
| EPS in Rs | -0.01 | 0 | 0 | 0 | -0.06 | -0.02 | -0.03 | -0.03 | -0.02 | -0.1 | -0.05 | -0.1 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | -0.04 | 0 | 0 | 0 | 1.27 | 1.94 |
| Expenses | 0.05 | 0.1 | 0.15 | 0.06 | 0.04 | 0 | 0.02 | 0.14 | 1.52 | 2.27 |
| Operating Profit | -0.05 | -0.1 | -0.15 | -0.06 | -0.08 | 0 | -0.02 | -0.14 | -0.25 | -0.33 |
| OPM % | — | — | — | — | — | — | — | — | -19.69 | -17.01 |
| Other Income | 0.03 | 0.02 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.02 | -0.08 | 0 | -0.06 | -0.08 | 0 | -0.02 | -0.14 | -0.25 | -0.33 |
| Tax % | 0 | 0 | — | 0 | 0 | — | 0 | 0 | 0 | — |
| Net Profit | -0.02 | -0.08 | 0 | -0.06 | -0.08 | 0 | -0.02 | -0.14 | -0.25 | -0.33 |
| EPS in Rs | -0.02 | -0.07 | 0 | -0.05 | -0.07 | 0 | -0.02 | -0.12 | -0.21 | -0.27 |
| Dividend Payout % | 0 | 0 | — | 0 | 0 | — | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 |
| Reserves | -2.51 | -2.53 | -2.61 | -2.86 | -2.92 | -3 | -3 | -3.21 | -3.35 | -4.24 |
| Borrowings | 0.01 | 0.17 | 0.21 | 0 | 0 | 0 | 0.08 | 0.04 | 0.25 | 1.47 |
| Other Liabilities | 0.13 | 0.14 | 0.19 | 0.13 | 0.15 | 0.18 | 0.11 | 0.17 | 0.12 | 0.94 |
| Total Liabilities | 0.64 | 0.79 | 0.8 | 0.28 | 0.24 | 0.19 | 0.2 | 0.01 | 0.03 | 1.18 |
| Fixed Assets | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0 | 0 | 0 |
| Other Assets | 0.44 | 0.59 | 0.6 | 0.08 | 0.04 | -0.01 | 0 | 0.01 | 0.03 | 1.18 |
| Total Assets | 0.64 | 0.79 | 0.8 | 0.28 | 0.24 | 0.19 | 0.2 | 0.01 | 0.03 | 1.18 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.04 | 0.01 | -0.02 | -0.01 | -0.01 | -0.04 | 0.01 | -0.01 | -0.19 | -0.59 |
| Cash from Investing Activity | 0.07 | -0.07 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | 0 | 0.16 | 0.04 | 0 | 0 | 0 | 0 | 0.01 | 0.21 | 0.58 |
| Net Cash Flow | 0.03 | 0.1 | 0.01 | -0.01 | -0.01 | 0 | 0.01 | 0 | 0.02 | -0.01 |
| Free Cash Flow | -0.04 | 0.01 | -0.02 | -0.01 | -0.01 | -0.04 | 0.01 | -0.01 | -0.19 | -0.59 |
| CFO/OP | 67 | -20 | 20 | 7 | 17 | 50 | — | 50 | 136 | 236 |

### Ratios

| Item | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 1703.33 | — | — | — | — | 0 | — | — | — | 172.44 |
| Inventory Days | — | — | — | — | — | 0 | — | — | — | 0 |
| Cash Conversion Cycle | 1703.33 | — | — | — | — | 0 | — | — | — | 172.44 |
| Working Capital Days | 1460 | — | — | — | — | -1642.5 | — | — | — | -359.25 |
| ROCE % | -11.11 | -3.45 | -12.7 | — | -50 | -160 | 0 | — | — | -333.33 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% | 41.3% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 51.98% | 51.98% | 51.97% | 51.97% | 51.97% | 47.58% | 44.08% | 45.96% | 45.99% | 45.99% | 45.88% | 45.86% |
| Others | 6.73% | 6.73% | 6.74% | 6.74% | 6.74% | 11.12% | 14.62% | 12.74% | 12.71% | 12.71% | 12.82% | 12.85% |
| No. of Shareholders | 2440 | 2440 | 2432 | 2431 | 2430 | 2430 | 2427 | 2426 | 2427 | 503 | 2475 | 2465 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 1 / 5

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 54.45 | Buy |
| EMA (10) | 54.46 | Buy |
| SMA (20) | 49.17 | Buy |
| EMA (20) | 49.57 | Buy |
| SMA (50) | 38.06 | Buy |
| EMA (50) | 42.48 | Buy |
| SMA (100) | 39.18 | Buy |
| EMA (100) | 37.62 | Buy |
| SMA (200) | 27.46 | Buy |
| EMA (200) | 30.16 | Buy |

### Oscillators — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 93.31 | Sell |
| MACD (12,26,9) | 6.02 | Buy |
| Stochastic (14,3,3) | 100 | Sell |
| ADX (14) | 68.29 | Buy |
| Williams %R (14) | 0 | Sell |
| ATR (14) | 1.35 | Neutral |
| ROC (12) | 26.65 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 98.83 | Sell |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Q3 & 9M FY26 standalone results: Q3 revenue Rs34.56L, Q3 loss Rs12.39L; 9M revenue Rs54.18L, 9M loss Rs19.42L. | [Financial Results For The Quarter And Nine Months Ended On 31St December, 2025. 9 Feb - Q3 & 9M FY26 standalone results: Q3 revenue Rs34.56L, Q3 loss Rs12.39L; 9M revenue Rs54.18L, 9M loss Rs19.42L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/38bc95b0-fd3e-4b40-ae4f-0e2839e02d95.pdf) |
| 8h - Board approved 100% Radiant acquisition for ₹4,62,77,500 via 46,27,750-share swap; EGM April 10, 2026. | [Board Meeting Outcome for Outcome Of Board Meeting 8h - Board approved 100% Radiant acquisition for ₹4,62,77,500 via 46,27,750-share swap; EGM April 10, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/cad52670-b51f-4531-b623-f32224b956e3.pdf) |
| 6 Feb - Approved standalone Q3 and nine-month results to 31 Dec 2025: Q3 revenue Rs34.56L, nine-month loss Rs19.42L. | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 06Th February, 2026 6 Feb - Approved standalone Q3 and nine-month results to 31 Dec 2025: Q3 revenue Rs34.56L, nine-month loss Rs19.42L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c3356bc-d89e-42a7-b844-c514f270aafc.pdf) |
| 6 Apr - Rekvina Labs says Annual Secretarial Compliance Report is not applicable under Regulation 15(2) exemption. | [Compliances-Reg.24(A)-Annual Secretarial Compliance 6 Apr - Rekvina Labs says Annual Secretarial Compliance Report is not applicable under Regulation 15(2) exemption.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a1ff1749-e70f-4a77-9fd6-8b3e36b8baf6.pdf) |
| 2h - Board meeting March 16, 2026 to consider preferential issue of equity/other securities; trading window closed until 48 hours after meeting. | [Board Meeting Intimation for PREFERENTIAL ISSUE 2h - Board meeting March 16, 2026 to consider preferential issue of equity/other securities; trading window closed until 48 hours after meeting.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1551bc0f-3589-451a-8d49-db73b610d658.pdf) |
| 29 Jan - Chetanbhai Patel resigned as Non-Executive Independent Director (DIN 06373484) effective 29 Jan 2026, citing personal reasons. | [Announcement under Regulation 30 (LODR)-Change in Directorate 29 Jan - Chetanbhai Patel resigned as Non-Executive Independent Director (DIN 06373484) effective 29 Jan 2026, citing personal reasons.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/12e5db41-d024-4080-b7ee-42198fb1a440.pdf) |
| 29 Jan - Board meeting 6 Feb 2026 to approve Q3/Nine-month Dec 31, 2025 unaudited Ind AS results; trading window closed. | [Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 6Th February, 2026 29 Jan - Board meeting 6 Feb 2026 to approve Q3/Nine-month Dec 31, 2025 unaudited Ind AS results; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a6ed2f59-42ce-4796-8850-e85e540cb8e4.pdf) |
| 29 Jan - Appointment of Jay Chintan Patel (DIN:10147916) as Independent Director from 29-Jan-2026 for five-year term. | [Announcement under Regulation 30 (LODR)-Change in Directorate 29 Jan - Appointment of Jay Chintan Patel (DIN:10147916) as Independent Director from 29-Jan-2026 for five-year term.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f0716f61-e01d-41b8-8189-9a556d22b7c3.pdf) |
| 24 Mar - Open Offer for 28,90,100 shares (26%) at ₹10; preferential issue 46,27,750 shares; control consolidation. | [Detailed Public Statement 24 Mar - Open Offer for 28,90,100 shares (26%) at ₹10; preferential issue 46,27,750 shares; control consolidation.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/C051A504-B7FD-4DE6-9621-A80C8A9C4BE8-142309.pdf) |
| 24 Mar - Open Offer for 28,90,100 shares (26%) at ₹10 each; DPS published March 24, 2026. | [Announcement under Regulation 30 (LODR)-Open Offer - Updates 24 Mar - Open Offer for 28,90,100 shares (26%) at ₹10 each; DPS published March 24, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/57e66a3e-a14c-498f-889f-180d4c9ab6d3.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Shareholders Meeting To Be Held On 29.09.2026 Through Online Mode](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0ca584d-61f2-4d28-be39-8e16ffe033c6.pdf) |
| 2026-09-03 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f7f0cf8-4ca5-4045-b8bc-dae657ee9a57.pdf) |
| 2026-09-02 | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0729c464-60f9-4925-ab5d-f368f504954e.pdf) |
| 2026-08-18 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2246DB73_E32A_4289_8E1A_8C92E2053A34_104141.pdf) |
| 2026-08-17 | [Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=AF44C003_66D1_4641_9379_F3A6149918A7_151456.pdf) |
| 2026-08-14 | [Clarification On Price Movement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ce019f1-9753-4613-9b01-8018f4f9a1be.pdf) |
| 2026-08-13 | [Board Meeting Outcome for OUTCOME OF BOARD MEETING](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a7f16f9-2ef2-49e8-8568-b808fd7734ce.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Allotment](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd6a7617-9dc4-4a20-bf83-7fd22de1ddee.pdf) |
| 2026-08-01 | [Announcement under Regulation 30 (LODR)-Open Offer - Updates](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a274499-75d9-40b3-b3a3-9452377ddd5e.pdf) |
| 2026-08-01 | [Board Meeting Intimation for Consideration Of Unaudited Financial Result For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ca09d685-6b6d-4f31-b035-15738f2a5801.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [FINANCIAL RESULTS QTR1](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4119df5c-62c0-49eb-95d7-e2e8e6db3245.pdf) |
| 2026-05-21 | [Financial Results For Quarter Ended & Year Ended On March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d164edfb-4465-48d3-9e1e-83f43cd2b1e6.pdf) |
| 2026-02-09 | [Financial Results For The Quarter And Nine Months Ended On 31St December 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38bc95b0-fd3e-4b40-ae4f-0e2839e02d95.pdf) |
| 2025-11-14 | [Standalone Financial Result For The Period Ended On 30 September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=428f65cc-c4ea-49df-82f0-243a088d1408.pdf) |
| 2025-08-13 | [Financial Results QTR 1](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2c172f3-02c7-4d3e-bd03-2156d9fbe3b1.pdf) |
| 2025-05-30 | [FINANCIAL RESULTS FOR 4TH QTR AND YEAR ENEDED 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6506de57-447e-4072-bfdb-0cff8a5b6d11.pdf) |
| 2025-01-20 | [Quarter And Nine Months Ended On 31St December 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36f47678-c418-4657-92d4-4d590e27da1e.pdf) |
| 2024-11-14 | [Financial Result For Quarter And Half Year Ended On 30Th September 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0085cab4-12ac-4b2c-ae98-144d1a7a6852.pdf) |
| 2024-07-29 | [Outcome Of The Board Meeting Dated 29.07.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99877efb-f870-4390-8a79-ac5715723f0d.pdf) |
| 2024-05-30 | [Financial Results For The Year Ended On 31St March, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa1eb34a-f0ab-4667-9506-be9b72f456b6.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a760bf51-6a75-4909-901b-4736c1e180b4.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/92d28464-8180-4d9f-a69e-d9cb01f1f3ba.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9596503-9d8a-4bf6-af23-fda6fcea97d0.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/049a1b6c-8f1b-4541-92a9-6262584d90ac.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ae6a6891-4715-4371-bce3-773917f29042.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b5ad8fbc-7162-4a63-94d4-ab72fe338fb1.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/91ff8727-aa16-45e1-bc71-3f8aca8ccabe.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c1ce393a-d8f7-445d-9f98-0965c9cc949d.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/639df4ee-851e-4804-9a33-e59549c5a880.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/47910461-e56a-44e1-a67e-111763cd1b97.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ca329cc1-7455-4991-8382-525dc48cb242.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dfc8e27e-8284-4d32-a3a0-54568534a85b.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/19915cbb-6027-480d-b5e0-eb8141746248.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ac70b241-3c57-4fdd-b3f3-e60dc70df4d3.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0e7b46b3-988a-4d9a-a00a-e86e0b86ea6b.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f58b779f-4e0e-4e61-8329-cbfb347f7bbd.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532707/75723532707.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6bffaf97-5d12-4bb3-bf93-4431d0c71a04.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532707/70277532707_06_09_21.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9fa18f76-0287-446d-add8-aced734d478e.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:50:19.306Z.